Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms

BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor burden, such as high white blood cell count or splenomegaly, should be carefully considered to prevent TLS.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Sagou, Ken, Ito, Makoto, Kawamura, Yuma, Ukai, Shun, Goto, Miyo, Fukushima, Nobuaki, Ozeki, Kazutaka, Fukuyama, Ryuichi, Kohno, Akio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869312/
https://ncbi.nlm.nih.gov/pubmed/33598264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados